AU2003260509A1 - Acetylene compounds - Google Patents

Acetylene compounds

Info

Publication number
AU2003260509A1
AU2003260509A1 AU2003260509A AU2003260509A AU2003260509A1 AU 2003260509 A1 AU2003260509 A1 AU 2003260509A1 AU 2003260509 A AU2003260509 A AU 2003260509A AU 2003260509 A AU2003260509 A AU 2003260509A AU 2003260509 A1 AU2003260509 A1 AU 2003260509A1
Authority
AU
Australia
Prior art keywords
acetylene compounds
acetylene
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003260509A
Inventor
Frank Ellis
Heather Elizabeth Fulton
Adrian Hall
Albert Andrzej Jaxa-Chamiec
Stephen Swanson
Sadie Vile
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2003260509A1 publication Critical patent/AU2003260509A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003260509A 2002-09-18 2003-09-16 Acetylene compounds Abandoned AU2003260509A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0221694.3 2002-09-18
GBGB0221694.3A GB0221694D0 (en) 2002-09-18 2002-09-18 Compounds
PCT/EP2003/010350 WO2004026890A1 (en) 2002-09-18 2003-09-16 Acetylene compounds

Publications (1)

Publication Number Publication Date
AU2003260509A1 true AU2003260509A1 (en) 2004-04-08

Family

ID=9944337

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003260509A Abandoned AU2003260509A1 (en) 2002-09-18 2003-09-16 Acetylene compounds

Country Status (5)

Country Link
AR (1) AR041269A1 (en)
AU (1) AU2003260509A1 (en)
GB (1) GB0221694D0 (en)
TW (1) TW200413402A (en)
WO (1) WO2004026890A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5594722B2 (en) * 2010-01-28 2014-09-24 国立大学法人東北大学 Method for producing intermediate compound for preparing RNA-type unnatural nucleoside derivative
SG188497A1 (en) 2010-09-22 2013-05-31 Alios Biopharma Inc Substituted nucleotide analogs
CA2860234A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
US8916538B2 (en) 2012-03-21 2014-12-23 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723590D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
US20040162422A1 (en) * 2001-03-20 2004-08-19 Adrian Hall Chemical compounds

Also Published As

Publication number Publication date
WO2004026890A1 (en) 2004-04-01
TW200413402A (en) 2004-08-01
AR041269A1 (en) 2005-05-11
GB0221694D0 (en) 2002-10-30

Similar Documents

Publication Publication Date Title
AU2003266949A1 (en) Compounds
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones
AU2003235759A1 (en) 4-dedimethylamino tetracycline compounds
AU2003279366A1 (en) Novel compounds
WO2003072535A8 (en) Substituted hydroxyethylamines
AU2003238043A1 (en) Substituted imidazotriazines
AU2003287178A1 (en) Chemical compounds
AU2003245984A1 (en) Hetero-cyclicaly substituted imidazotriazines
AU2003290661A1 (en) Chemical compounds
AU2003294900A1 (en) Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides
AU2003218170A1 (en) Autoinducer compounds
AU2003216859A1 (en) Amidoacetonitrile compounds
AU2003212366A1 (en) Substituted 4-aminocyclohexanols
AU2003284217A1 (en) Chemical compounds
AU2003249294A1 (en) Fullerene compounds
AU2003260509A1 (en) Acetylene compounds
AUPS044102A0 (en) New compound
AU2002952559A0 (en) New use
AU2002951868A0 (en) Compound i
AU2003292667A1 (en) Benzocycloheptapyridine compounds
AU2003251259A1 (en) Novel compounds
AU2003275480A1 (en) Compounds
AU2003255322A1 (en) Compounds
AU2003232510A1 (en) Alkyne compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase